Atria Investments LLC increased its position in Monsanto Company (NYSE:MON) by 0.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,912 shares of the basic materials company’s stock after buying an additional 46 shares during the period. Atria Investments LLC’s holdings in Monsanto were worth $581,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. Raymond James Trust N.A. raised its stake in Monsanto by 95.1% in the first quarter. Raymond James Trust N.A. now owns 7,533 shares of the basic materials company’s stock worth $853,000 after buying an additional 3,671 shares during the period. Creative Planning raised its stake in Monsanto by 0.7% in the first quarter. Creative Planning now owns 24,709 shares of the basic materials company’s stock worth $2,797,000 after buying an additional 171 shares during the period. Chesley Taft & Associates LLC bought a new stake in Monsanto during the first quarter worth about $6,828,000. Gulf International Bank UK Ltd raised its stake in Monsanto by 1.2% in the first quarter. Gulf International Bank UK Ltd now owns 135,274 shares of the basic materials company’s stock worth $15,313,000 after buying an additional 1,600 shares during the period. Finally, Augustine Asset Management Inc. raised its stake in Monsanto by 2.4% in the first quarter. Augustine Asset Management Inc. now owns 20,094 shares of the basic materials company’s stock worth $2,274,000 after buying an additional 462 shares during the period. 74.88% of the stock is owned by institutional investors and hedge funds.
Shares of Monsanto Company (NYSE MON) traded down 0.02% during trading on Friday, reaching $117.84. The company’s stock had a trading volume of 848,872 shares. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97. The company has a market cap of $51.77 billion, a PE ratio of 25.45 and a beta of 1.07. The stock’s 50 day moving average price is $117.53 and its 200 day moving average price is $114.70.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The firm had revenue of $4.23 billion for the quarter, compared to analysts’ expectations of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The business’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.17 EPS. Equities research analysts predict that Monsanto Company will post $4.89 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, July 7th were paid a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 1.83%. The ex-dividend date of this dividend was Wednesday, July 5th. Monsanto’s payout ratio is 46.75%.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://stocknewstimes.com/2017/08/06/monsanto-company-nysemon-shares-bought-by-atria-investments-llc.html.
A number of analysts have recently issued reports on MON shares. Citigroup Inc. reissued a “neutral” rating and issued a $125.00 price target (up from $122.00) on shares of Monsanto in a research report on Friday, April 14th. Zacks Investment Research raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price target for the company in a research report on Friday, June 16th. UBS AG lowered shares of Monsanto from a “positive” rating to a “neutral” rating in a research report on Tuesday, June 27th. Susquehanna Bancshares Inc reissued a “neutral” rating and issued a $128.00 price target (up from $125.00) on shares of Monsanto in a research report on Tuesday, June 27th. Finally, Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target for the company in a research report on Tuesday, June 27th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have issued a buy rating to the company’s stock. Monsanto currently has a consensus rating of “Hold” and an average price target of $123.15.
In other news, SVP Janet M. Holloway sold 7,423 shares of the company’s stock in a transaction that occurred on Tuesday, June 13th. The stock was sold at an average price of $118.00, for a total transaction of $875,914.00. Following the sale, the senior vice president now owns 33,645 shares in the company, valued at approximately $3,970,110. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert T. Fraley sold 52,410 shares of the company’s stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. Insiders sold a total of 74,470 shares of company stock worth $8,791,281 in the last 90 days. Company insiders own 0.79% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.
